psoriasis
Conditions
Interventions
Guselkumab therapy Group:None
Ustekinumab therapy Group:None
Secukinumab therapy Group:None
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Age = 18 (2)Plaque psoriasis with BSA = 3%
Exclusion criteria
Exclusion criteria: (1)Patients with seriously infect (2)Patients with active tuberculosis (3)Patients with multiple sclerosis or other demyelinating diseases, or with multiple sclerosis or other demyelinating diseases in their first degree relatives (4)Patients with heart failure (cardiac function grade III or IV) (5)Patients with severe liver disease, or chronic hepatitis B and hepatitis C have obvious liver function damage (6)Patients receiving treatment for malignant tumors (7)Pregnant and lactating women or recent birth planners (8)Patients with immunodeficiency (9)Patients who are allergic to the pharmaceutical ingredients contained in biological agents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis Area and Severity Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Surface Area;Dermatology Life Quality Index; | — |
Countries
China
Contacts
Public ContactXue-jun Zhang
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed